$47.28
0.120.25%
At close: Dec 15, 4:00 PM EST
$47.28
N/A
After Hours: 4:00 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Supernus Pharmaceuticals Short Interest Report
SUPNNASDAQ
Supernus Pharmaceuticals Stock Short Interest Report | NASDAQ:SUPN | Benzinga
Short interest in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) decreased during the last reporting period, falling from 5.20M to 4.99M. This put 13.54% of the company's publicly available shares short.
Based on the recent average volume of 734.43K shares traded per day, it would take 6.8 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
4.99M
Short Interest %
13.5%
Days to Cover
6.8
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| SUPN | Supernus Pharmaceuticals, Inc. | 11/28/2025 | 12/09/2025 | 13.54% | 36,885,230 | 4,994,703 | 734,433 | 6.8 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 11/14/2025 | 11/25/2025 | 14.11% | 36,885,230 | 5,202,679 | 1,413,026 | 3.68 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 10/31/2025 | 11/11/2025 | 13.20% | 36,885,230 | 4,870,017 | 778,713 | 6.25 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 10/15/2025 | 10/24/2025 | 13.43% | 36,885,230 | 4,954,765 | 794,110 | 6.24 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 09/30/2025 | 10/09/2025 | 14.06% | 36,885,230 | 5,186,700 | 742,793 | 6.98 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 09/15/2025 | 09/24/2025 | 13.61% | 36,885,230 | 5,019,809 | 610,010 | 8.23 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 08/29/2025 | 09/10/2025 | 13.02% | 36,885,230 | 4,801,288 | 645,724 | 7.44 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 08/15/2025 | 08/26/2025 | 12.74% | 36,885,230 | 4,700,980 | 1,274,707 | 3.69 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 13.78% | 36,885,230 | 5,080,993 | 805,340 | 6.31 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 13.82% | 36,885,230 | 5,098,408 | 686,534 | 7.43 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 13.28% | 36,885,230 | 4,897,876 | 817,017 | 5.99 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 10.93% | 36,885,230 | 4,029,853 | 513,980 | 7.84 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 11.46% | 36,885,230 | 4,226,219 | 429,844 | 9.83 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 11.32% | 36,885,230 | 4,177,164 | 480,604 | 8.69 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 10.76% | 36,885,230 | 3,968,741 | 352,504 | 11.26 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 11.23% | 36,885,230 | 4,144,037 | 690,288 | 6 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 12.64% | 36,885,230 | 4,660,849 | 548,569 | 8.5 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 13.65% | 36,885,230 | 5,034,971 | 820,529 | 6.14 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 16.43% | 36,885,230 | 6,061,066 | 953,484 | 6.36 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 15.50% | 36,885,230 | 5,716,495 | 397,215 | 14.39 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 15.81% | 36,290,007 | 5,738,334 | 287,387 | 19.97 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 16.58% | 36,290,007 | 6,017,873 | 370,079 | 16.26 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 17.19% | 36,044,988 | 6,197,909 | 390,356 | 15.88 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 18.42% | 36,044,988 | 6,637,775 | 318,957 | 20.81 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 17.91% | 36,044,988 | 6,454,291 | 253,016 | 25.51 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 18.10% | 36,044,988 | 6,523,901 | 550,630 | 11.85 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 18.87% | 36,044,988 | 6,803,373 | 248,965 | 27.33 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 18.78% | 36,044,988 | 6,769,850 | 293,420 | 23.07 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 19.34% | 36,044,988 | 6,970,316 | 385,553 | 18.08 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 18.86% | 36,044,988 | 6,798,029 | 433,995 | 15.66 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 18.50% | 36,044,988 | 6,667,905 | 269,605 | 24.73 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 17.10% | 36,044,988 | 6,161,942 | 508,029 | 12.13 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 17.51% | 36,044,988 | 6,310,884 | 318,207 | 19.83 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 16.99% | 36,044,988 | 6,123,573 | 1,040,992 | 5.88 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 16.19% | 36,044,988 | 5,833,970 | 560,294 | 10.41 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 14.48% | 36,044,988 | 5,218,973 | 657,257 | 7.94 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 13.64% | 36,044,988 | 4,914,858 | 518,334 | 9.48 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 13.37% | 36,044,988 | 4,820,516 | 323,000 | 14.92 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 12.99% | 36,044,488 | 4,681,164 | 356,277 | 13.14 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 13.27% | 36,340,655 | 4,822,753 | 484,691 | 9.95 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 13.55% | 36,340,655 | 4,924,006 | 464,890 | 10.59 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 12.13% | 36,340,655 | 4,408,451 | 478,402 | 9.21 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 10.33% | 36,238,546 | 3,741,641 | 379,888 | 9.85 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 12.43% | 36,238,546 | 4,503,911 | 261,665 | 17.21 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 12.39% | 36,238,546 | 4,488,786 | 292,959 | 15.32 | Get Alert |
| SUPN | Supernus Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 12.27% | 36,238,546 | 4,448,242 | 454,012 | 9.8 | Get Alert |
Looking for the most shorted stocks?
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved